SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Livent Corp. – ‘10-Q’ for 9/30/22 – ‘EX-31.1’

On:  Thursday, 11/3/22, at 4:06pm ET   ·   For:  9/30/22   ·   Accession #:  1742924-22-33   ·   File #:  1-38694

Previous ‘10-Q’:  ‘10-Q’ on 8/4/22 for 6/30/22   ·   Next:  ‘10-Q’ on 5/4/23 for 3/31/23   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23   ·   1 Reference:  To:  Livent Corp. – ‘8-K’ on / for 9/2/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

11/03/22  Livent Corp.                      10-Q        9/30/22   81:7.5M

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.61M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     27K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
11: R1          Cover page                                          HTML     74K 
12: R2          Condensed Consolidated Statements of Operations     HTML    107K 
13: R3          Condensed Consolidated Statements of Comprehensive  HTML     60K 
                Income/(Loss)                                                    
14: R4          Condensed Consolidated Statements of Comprehensive  HTML     30K 
                Income/(Loss) (Parenthetical)                                    
15: R5          Condensed Consolidated Balance Sheets               HTML    134K 
16: R6          Condensed Consolidated Balance Sheets               HTML     40K 
                (Parenthetical)                                                  
17: R7          Condensed Consolidated Statements of Cash Flows     HTML    144K 
18: R8          Condensed Consolidated Statements of Cash Flows     HTML     24K 
                (Parenthetical)                                                  
19: R9          Condensed Consolidated Statements of Equity         HTML     97K 
20: R10         Condensed Consolidated Statements of Equity         HTML     25K 
                (Parenthetical)                                                  
21: R11         Description of the Business                         HTML     26K 
22: R12         Principal Accounting Policies and Related           HTML     32K 
                Financial Information                                            
23: R13         Recently Issued and Adopted Accounting              HTML     37K 
                Pronouncements and Regulatory Items                              
24: R14         Revenue Recognition                                 HTML     70K 
25: R15         Inventories, Net                                    HTML     31K 
26: R16         Investments                                         HTML     26K 
27: R17         Restructuring and Other Charges                     HTML     40K 
28: R18         Income Taxes                                        HTML     28K 
29: R19         Debt                                                HTML     54K 
30: R20         Equity                                              HTML     61K 
31: R21         Earnings/(Loss) Per Share                           HTML     61K 
32: R22         Financial Instruments, Risk Management and Fair     HTML    120K 
                Value Measurements                                               
33: R23         Commitments and Contingencies                       HTML     56K 
34: R24         Supplemental Information                            HTML     71K 
35: R25         Recently Issued and Adopted Accounting              HTML     36K 
                Pronouncements and Regulatory Items (Policies)                   
36: R26         Principal Accounting Policies and Related           HTML     26K 
                Financial Information (Tables)                                   
37: R27         Revenue Recognition (Tables)                        HTML     65K 
38: R28         Inventories, Net (Tables)                           HTML     32K 
39: R29         Restructuring and Other Charges (Tables)            HTML     41K 
40: R30         Debt (Tables)                                       HTML     45K 
41: R31         Equity (Tables)                                     HTML     61K 
42: R32         Earnings/(Loss) Per Share (Tables)                  HTML     60K 
43: R33         Financial Instruments, Risk Management and Fair     HTML    117K 
                Value Measurements (Tables)                                      
44: R34         Commitments and Contingencies (Tables)              HTML     52K 
45: R35         Supplemental Information (Tables)                   HTML     73K 
46: R36         Principal Accounting Policies and Related           HTML     43K 
                Financial Information - Narrative (Details)                      
47: R37         Principal Accounting Policies and Related           HTML     30K 
                Financial Information - Fair Value Assumptions                   
                (Details)                                                        
48: R38         Revenue Recognition - Disaggregation of Revenue by  HTML     46K 
                Major Geographical Region (Details)                              
49: R39         Revenue Recognition - Narrative (Details)           HTML     36K 
50: R40         Revenue Recognition - Disaggregation of Revenue By  HTML     37K 
                Major Product Category (Details)                                 
51: R41         Revenue Recognition - Contract Assets and           HTML     32K 
                Liabilities (Details)                                            
52: R42         Revenue Recognition - Performance Obligations       HTML     35K 
                (Details)                                                        
53: R43         Inventories, Net - Schedule of Inventory (Details)  HTML     32K 
54: R44         Investments (Details)                               HTML     55K 
55: R45         Restructuring and Other Charges - Restructuring     HTML     36K 
                Charges in Consolidated Income (Details)                         
56: R46         Income Taxes (Details)                              HTML     29K 
57: R47         Debt - Long-term Debt (Details)                     HTML     57K 
58: R48         Debt - Narrative (Details)                          HTML     93K 
59: R49         Equity - Additional Information (Details)           HTML     44K 
60: R50         Equity - Summary of Common Stock Activity           HTML     47K 
                (Details)                                                        
61: R51         Equity - Schedule of Accumulated Other              HTML     50K 
                Comprehensive Loss) (Details)                                    
62: R52         Earnings/(Loss) Per Share - EPS Calculation         HTML     62K 
                (Details)                                                        
63: R53         Earnings/(Loss) Per Share - Weighted Average Share  HTML     31K 
                Equivalents (Details)                                            
64: R54         Earnings/(Loss) Per Share - Narrative (Details)     HTML     31K 
65: R55         Financial Instruments, Risk Management and Fair     HTML     37K 
                Value Measurements - Narrative (Details)                         
66: R56         Financial Instruments, Risk Management and Fair     HTML     33K 
                Value Measurements - Schedule of Derivatives                     
                (Details)                                                        
67: R57         Financial Instruments, Risk Management and Fair     HTML     42K 
                Value Measurements - Derivatives in Cash Flow                    
                Hedging Relationships (Details)                                  
68: R58         Financial Instruments, Risk Management and Fair     HTML     30K 
                Value Measurements - Derivatives Not Designated As               
                Cash Flow Hedging Instruments (Details)                          
69: R59         Financial Instruments, Risk Management and Fair     HTML     54K 
                Value Measurements - Recurring Fair Value                        
                Measurements (Details)                                           
70: R60         Commitments and Contingencies - Narrative           HTML     33K 
                (Details)                                                        
71: R61         Commitments and Contingencies - Lease Cost and      HTML     38K 
                Terms (Details)                                                  
72: R62         Commitments and Contingencies - Maturity of         HTML     41K 
                Operating Lease Liabilities (Details)                            
73: R63         Supplemental Information - Prepaid and Other        HTML     40K 
                Current Assets (Details)                                         
74: R64         Supplemental Information - Other Assets (Details)   HTML     41K 
75: R65         Supplemental Information - Accrued and Other        HTML     47K 
                Current Liabilities (Details)                                    
76: R66         Supplemental Information - Other Long-Term          HTML     43K 
                Liabilities (Details)                                            
79: XML         IDEA XML File -- Filing Summary                      XML    147K 
77: XML         XBRL Instance -- lthm-20220930_htm                   XML   1.90M 
78: EXCEL       IDEA Workbook of Financial Reports                  XLSX    133K 
 7: EX-101.CAL  XBRL Calculations -- lthm-20220930_cal               XML    236K 
 8: EX-101.DEF  XBRL Definitions -- lthm-20220930_def                XML    506K 
 9: EX-101.LAB  XBRL Labels -- lthm-20220930_lab                     XML   1.47M 
10: EX-101.PRE  XBRL Presentations -- lthm-20220930_pre              XML    897K 
 6: EX-101.SCH  XBRL Schema -- lthm-20220930                         XSD    146K 
80: JSON        XBRL Instance as JSON Data -- MetaLinks              414±   615K 
81: ZIP         XBRL Zipped Folder -- 0001742924-22-000033-xbrl      Zip    379K 


‘EX-31.1’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  

Exhibit 31.1
CHIEF EXECUTIVE OFFICER CERTIFICATION
I, Paul W. Graves, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Livent Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 3, 2022

/s/ Paul W. Graves
Paul W. Graves
President and Chief Executive Officer
 


Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/3/22None on these Dates
For Period end:9/30/22
 List all Filings 


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/02/22  Livent Corp.                      8-K:1,2,9   9/02/22   11:78M
Top
Filing Submission 0001742924-22-000033   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 11:34:56.2pm ET